.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
US Department of Justice
Fuji
Novartis
Johnson and Johnson
Citi
Boehringer Ingelheim
Colorcon
Medtronic
Moodys

Generated: June 22, 2017

DrugPatentWatch Database Preview

ORGARAN Drug Profile

« Back to Dashboard

What is the patent landscape for Orgaran, and when can generic versions of Orgaran launch?

Orgaran is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in ORGARAN is danaparoid sodium. There is one drug master file entry for this compound. Additional details are available on the danaparoid sodium profile page.

Summary for Tradename: ORGARAN

Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ORGARAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc
ORGARAN
danaparoid sodium
INJECTABLE;INJECTION020430-001Dec 24, 1996DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ORGARAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen Global Inc
ORGARAN
danaparoid sodium
INJECTABLE;INJECTION020430-001Dec 24, 19965,164,377► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Covington
Colorcon
Cantor Fitzgerald
Cerilliant
Novartis
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot